MIST – milestone pharmaceuticals inc. - common shares (US:NASDAQ)

News

Milestone® Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Milestone® Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
Milestone Pharmaceuticals (MIST) was downgraded by Zacks Research from "strong-buy" to "hold".
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com